Aloulou Annunziato Bacher Barata Barone Baumjohann Becher Beilhack Berberich-Siebelt Berod Bohle Bopp Borghans Brenner Buchholz Cumano Daniel De Sousa Delacher Diaz-Munoz Eberl Edinger Ellmeier Elo Fazilleau Gerlach Graca Gratz Heissmeyer Ho Hoffmann Hofmann Hogan Huber Huehn Huppa Iannacone Jeker Joller Kekäläinen Klein Krueger Lahesmaa Linterman Liston Martins McNamee Meerwijk Meyer-Hermann Mittrücker Müller Pace Perucha Peterson Piaggio Prinz Richard Roychoudhuri Rudin Salomon Samson Schlenner Schober Schumann Schurich Silva-Santos Soares Sparwasser Stein Stepanek Strid Vaeth Van Wijk Veldhoen Walker Wekerle Whithers Wolkers Zielinski
Arrow leftArrow right

Carolin Daniel,
Univ. Prof. Dr. phil. nat.

Professor of Immune Modulation

Carolin Daniel

Email:

carolin.daniel@helmholtz-muenchen.de

Logo LMU
Logo Helmholtz-Munich

Type 1 Diabetes Immunology (TDI)
Helmholtz Diabetes Center (HDC)
Helmholtz Zentrum München
German Research Center for Environmental Health

Heidemannstraße 1
80939 Munich
Germany

-------

Ludwig-Maximilians-Universität München
Department of Clinical Pharmacology
Immune Modulation

Lindwurmstrasse 2a
80337 Munich
Germany

Lab Website:

Coming asap.

Research Interests:

Our main research interest focusses on understanding regulatory T (Treg) cells in the immunopathology of autoimmune diseases such as Type 1 Diabetes (T1D). To do so, we combine the analysis of human immune cells from different disease stages with mechanistic studies in murine and humanized in vivo models. We focus on the following research topics:

  • We dissect key molecular mechanisms underpinning Treg cell impairments in autoimmunity as T1D.
  • We investigate the heterogeneity, plasticity and functional specialization of Treg cells in metabolic tissues of diabetes.

Our studies have the overarching goal of facilitating the future context-specific manipulation of Treg cells in (autoimmune) diabetes.